Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmaceutical Poisoning: Treatment Strategies

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

Encephalitis ll: Pathophysiology

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Characterization and effect of Naga Bhasma on hypoglycemic, antihyperglycemic, and antidiabetic activities in Charles Foster diabetic rats.

Journal of Ayurveda and integrative medicine·2025

Same author

Self-starting of Mamyshev oscillator using an optical beam shutter.

The Review of scientific instruments·2025

Same author

Exploring Anticancer Properties of Medicinal Plants against Breast Cancer by Downregulating Human Epidermal Growth Factor Receptor 2.

Journal of agricultural and food chemistry·2024

Same author

Comparision of traditional and laboratory methods of sulphur processing.

Journal of Ayurveda and integrative medicine·2023

Same author

Clinical Applications of Substance P (Neurokinin-1 Receptor) Antagonist in Canine Medicine.

Archives of Razi Institute·2022

Same author

Fabrication and analysis of enhanced thermal stability and high-sensitivity turnaround point long-period fiber grating.

Applied optics·2022

Search research articles

Related Experiment Video

Updated: May 22, 2026

Particle Agglutination Method for Poliovirus Identification

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

Pharmaceutical processing in panchakarma vis -a-vis polio myelitis.

A Chaube¹, P K Prajapati, S K Dixit

¹Department of Rasasastra, I.M.S., B.H.U., Varanasi - 221 005.

Ancient Science of Life

|May 5, 2012

Summary

Pharmaceutical processing alters medicated oil characteristics, impacting their therapeutic effects. Understanding these changes is crucial for effective drug formulation and delivery.

Related Experiment Videos

Last Updated: May 22, 2026

Particle Agglutination Method for Poliovirus Identification

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

Area of Science:

Pharmaceutical Sciences
Drug Delivery
Medicinal Chemistry

Background:

Medicated oils are widely used in pharmaceutical preparations.
The physical and chemical properties of medicaments are critical for their efficacy.
Variations in processing can significantly alter drug characteristics.

Purpose of the Study:

To highlight how pharmaceutical processing influences the physical and chemical characteristics of medicated oils.
To emphasize the impact of these changes on the therapeutic actions of medicaments.

Main Methods:

Review of existing literature on pharmaceutical processing of medicated oils.
Analysis of the relationship between processing parameters and physicochemical properties.
Correlation of altered properties with pharmacological outcomes.

Main Results:

Pharmaceutical processing methods lead to distinct physical and chemical profiles in medicated oils.
Changes in viscosity, solubility, and particle size are common outcomes of processing.
These alterations directly affect drug absorption, distribution, metabolism, and excretion (ADME) properties.

Conclusions:

The pharmaceutical processing of medicated oils is a critical determinant of their final characteristics.
Understanding these processing-induced changes is essential for optimizing drug performance and ensuring therapeutic efficacy.
Further research into tailored processing techniques can enhance the development of advanced medicated oil formulations.